It may be a stroke of good fortune that Optiscan is focusing on the Neurosurgery and Research markets.
The cost benefit equation would be very different. Both looking good I think.
- Forums
- ASX - By Stock
- Barrow Neurological Institute
It may be a stroke of good fortune that Optiscan is focusing on...
Featured News
Add OIL (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
0.020(12.5%) |
Mkt cap ! $150.3M |
Open | High | Low | Value | Volume |
16.0¢ | 18.0¢ | 15.5¢ | $37.32K | 230.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 18555 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.165 |
1 | 25000 | 0.160 |
6 | 208014 | 0.150 |
3 | 90000 | 0.145 |
1 | 50000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 18555 | 2 |
0.185 | 91667 | 2 |
0.195 | 38794 | 3 |
0.200 | 535139 | 3 |
0.205 | 100000 | 2 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |